Privia Health Group (PRVA)
NASDAQ:PRVA
Want to see PRVA full AI Analyst Report?
Earnings Data
Report Date
Aug 06, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.07Last Year’s EPS
0.02Same Quarter Last Year
Strong Buy
Based on 15 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed strong operational momentum — double‑digit provider and attributed‑lives growth, healthy practice collections growth, significant adjusted EBITDA expansion, margin improvement, and successful early integration of Evolent — supported by a large M&A pipeline and clear technology/AI initiatives to drive future efficiency. Offsetting factors included management’s conservative approach to full‑year guidance (except attributed lives), quarter‑to‑quarter volatility from prior‑year adjustments and shared‑savings timing, Q1 seasonality of cash flows, and payer/policy uncertainties (e.g., MA/V28 dynamics and variability in capitated vs. shared‑risk economics). Overall, the positives on growth, profitability, balance sheet flexibility, and execution materially outweighed the cited risks and uncertainties.Company Guidance
Provider and Attribution Growth
Implemented providers reached 5,535, a 13.6% increase year-over-year, with sequential growth of +155 from year-end 2025. Total value‑based attributed lives rose to ~1.6 million, up 26.5% year‑over‑year, driven by new provider signings and the addition of the Evolent ACO business.
Strong Revenue / Practice Collections Expansion
Practice collections for Q1 were $914.8 million, a 14.6% increase year‑over‑year, supported by provider growth, value‑based performance, and ambulatory utilization trends.
Material Adjusted EBITDA Growth and Margin Improvement
Adjusted EBITDA increased 36.3% year‑over‑year to $36.7 million. Adjusted EBITDA represented 28.5% of care margin, a 290 basis‑point expansion, demonstrating operating leverage across the platform.
Balance Sheet Strength and Cash / Cash Conversion Targets
Ended Q1 with $219.5 million in cash and no debt after typical Q1 outflows. Management reiterated a target to convert ~80% of full‑year adjusted EBITDA to free cash flow and reiterated full‑year guidance (with attributed lives range raised).
Attributed Lives by Payer — Diversified Mix with Strong Growth
Commercial attributed lives reached ~913,000 (+>17% YoY). CMS Medicare attributed lives increased ~62% YoY; Medicare Advantage and Medicaid attribution rose ~20% and ~36% YoY, respectively. The platform serves ~130+ commercial and government contracts.
M&A / Integration Momentum and Large Pipeline
Integration of the Evolent assets is ahead of schedule (tech and team integration progressing). Management highlighted a robust business development pipeline and the ability to acquire a range of assets (medical groups, ACOs, service entities) to grow density and scale.
Technology Leadership and AI Initiatives
New Chief Technology Officer hire with experience from Optum Insights; company is deploying generative AI across corporate, care‑center operations (prior auth, coding, referrals), and care delivery (chart prep, clinical decision support). Management expects AI-driven efficiency to help achieve long‑term EBITDA/care margin targets (30–35%).
Track Record of Multi‑Year EBITDA Growth
Over the last two years, Privia's EBITDA growth rate averaged ~32%. Management said achieving the midpoint of 2026 guidance would result in EBITDA more than doubling over the last three years, implying ~20% EBITDA growth at the $150 million midpoint.
PRVA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
PRVA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 07, 2026 | $23.99 | $23.99 | 0.00% |
Feb 26, 2026 | $22.65 | $24.91 | +9.98% |
Nov 06, 2025 | $25.02 | $23.98 | -4.16% |
Aug 07, 2025 | $19.78 | $19.51 | -1.37% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Privia Health Group (PRVA) report earnings?
Privia Health Group (PRVA) is schdueled to report earning on Aug 06, 2026, After Close (Confirmed).
What is Privia Health Group (PRVA) earnings time?
Privia Health Group (PRVA) earnings time is at Aug 06, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PRVA EPS forecast?
PRVA EPS forecast for the fiscal quarter 2026 (Q2) is 0.07.